Friday, March 5, 2021
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

ASM Expresses Support for the Global Health Security Act of 2021

by Global Biodefense Staff
January 21, 2021
FY21 Global Biosecurity Engagement Activities

Credit: Global Biodefense

The American Society for Microbiology (ASM), one of the largest life science societies composed of more than 30,000 scientists and health professionals, authored a letter of support for the Global Health Security Act of 2021, legislation co-sponsored by Rep. Gerry Connolly (D-VA) and Rep. Steve Chabot (R-OH).

The letter reads in part:

“A strong global health security (GHS) agenda is critical for international engagement and capacity building in public health. As an organization with an extensive global health program and scientists and public health workers on the front lines in countries all over the world, ASM understands firsthand the importance of securing our borders against both natural and intentional biological threats. The COVID-19 pandemic has taught us that our world is more interconnected than ever. What happens in environments in remote areas of the world can quickly become international public health emergencies because microbes are unimpeded by the construct of human borders.

In addition to supporting the bill’s establishment of a Global Health Security Agenda Interagency Review Council, we are pleased that the bill would establish a permanent position, Special Advisor to the President for Global Health Security, to serve as the coordinator of global health responses at all times. As we have seen over the past year, a point person to manage interagency communications is critical to avoiding confusion and miscommunication when a public health emergency occurs. We need to look no further than the COVID-19 pandemic to realize the responsibility we have to collaborate with nations around the globe when outbreaks arise. It is time for the United States to recommit to a strong, global health security agenda.”

ASM encouraged further consideration of genomic surveillance and clinical aspects involved in addressing global outbreaks as the bill moves forward.

Read the full letter at ASM.

Tags: Biden-Harris AdministrationEditor PickGlobal Health Security AgendaLegislativeOne Health

Related Posts

Medical Countermeasure Development
Funding News

2021 BAA for Development of Medical Countermeasures for Biological Threats

March 2, 2021
UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)
Funding News

UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)

March 2, 2021
New Coronavirus Variant: Here Is What Scientists Know About B1525
Biosurveillance

New Coronavirus Variant: Here Is What Scientists Know About B1525

March 2, 2021
How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines?
Medical Countermeasures

How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines?

March 2, 2021
Load More

Latest News

Medical Countermeasure Development

2021 BAA for Development of Medical Countermeasures for Biological Threats

March 2, 2021
UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)

UC San Diego Awarded NIH Funding for Rapid Acceleration of Diagnostics (RADx)

March 2, 2021
New Coronavirus Variant: Here Is What Scientists Know About B1525

New Coronavirus Variant: Here Is What Scientists Know About B1525

March 2, 2021
How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines?

How Does the Johnson & Johnson Vaccine Compare to the Other Coronavirus Vaccines?

March 2, 2021

Upcoming Events

Mar 5
Virtual Event
March 2 - March 5

Effectiveness of Non-Vaccine Influenza Control Measures

Mar 6
Virtual Event
March 6 - March 10

CROI 2021 – Conference on Retroviruses and Opportunistic Infections

Mar 8
Virtual Event
March 8 - March 10

Quantum-Enabled Sensing and Imaging for Biology

Mar 8
Virtual Event
2:00 pm - 3:30 pm

TRB Webinar: Visualizing Effects of COVID-19 on Transportation: A One-Year Retrospective

Mar 9
Virtual Event
March 9 - March 11

The Current Global Governance Landscape for Influenza

View More
Tweets by GlobalBioD

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2021 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe

© 2021 Stemar Media Group LLC